Popular Biotech News, Healthcare News and Pharma News

07:46 EDT 1st July 2016 | BioPortfolio

Congratulations to FDA’s Dr. Richard Pazdur, recipient of the AACR’s prestigious Distinguished Public Service Award

By: Stephen Ostroff, M.D. In the past five years, FDA’s Center for Drug Evaluation and Research (CDER) has approved more than 40 novel cancer treatments, offering hope to many patients who previously had few or no treatment options. Among these … Continue reading →

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

A mutation conferring resistance to novel irreversible EGFR inhibitors is identified in cell-free plasma DNA from lung cancer patients.

Hyponatremia with Neurontin

Hyponatremia has been added as a undesirable effect with unknown frequency to the summary of product characteristics for Neurontin (gabapentin; Pfizer).

A colloidal quantum dot spectrometer

Spectroscopy is carried out in almost every field of science, whenever light interacts with matter. Although sophisticated instruments with impressive performance characteristics are available, much effort continues to be invested in the development of miniaturized, cheap and easy-to-use systems. Current microspectrometer designs mostly use interference filters and interferometric optics that limi...

Large, non-saturating magnetoresistance in WTe2

Magnetoresistance is the change in a material’s electrical resistance in response to an applied magnetic field. Materials with large magnetoresistance have found use as magnetic sensors, in magnetic memory, and in hard drives at room temperature, and their rarity has motivated many fundamental studies in materials physics at low temperatures. Here we report the observation of an extremely large ...

The contribution of outdoor air pollution sources to premature mortality on a global scale

Assessment of the global burden of disease is based on epidemiological cohort studies that connect premature mortality to a wide range of causes, including the long-term health impacts of ozone and fine particulate matter with a diameter smaller than 2.5 micrometres (PM2.5). It has proved difficult to quantify premature mortality related to air pollution, notably in regions where air quality is no...

Facelift Dentistry's Dr. Sam Muslin Named 'LA's Top Cosmetic Dentist for 2015'

Peers give a nod of approval to a prominent West Coast dentist who is changing patients' health and quality of life with his VENLAY restorations and non-surgical Face Lift Dentistry method. “In many instances, Face Lift Dentistry would produce a better outcome - with less risk - than jaw surgery and braces.” – Dr. Sam Muslin ...

UPDATE 2-Philips, Osram lighting bidders to line up this month - sources

* Buyout groups to bid for Philips lamps unit end-Jan - sources

Cancer Moonshot Initiative: FDA To Form Virtual Oncology Center of Excellence

NIH and FDA would share $755m under FY 2017 budget proposal, part of $1bn the Obama Administration is targeting to jumpstart Moonshot.

GM mosquitoes fire first salvo against Zika virus : Trade Secrets

A Brazilian city in January became the first to approve a program to grow transgenic mosquitoes for their release into the environment as a public health measure against the Zika virus outbreak. The city of Piracicaba in Brazil said it would work in collaboration with the Milton Park, UK–based Oxitec to scale up release of transgenic Aedes aegypti mosquitoes, the main vector for the Zika, dengue...

FDA approves Gilead’s Odefsy for treatment of HIV-1 infection

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved its TAF-based single tablet regimen Odefsey (emtricitabine, rilpivirine and tenofovir alafenamide) for the treatment of HIV-1 infection in certain patients. read more

Sanofi's sarilumab beats Humira in head-to-head trial

Rheumatoid arthritis candidate was more effective than AbbVie's market-leader

ARITHMIE CARDIAQUE: Une heure de yoga par semaine suffit à calmer le rythme - l'European Journal of Cardiovascular Nursing

Le yoga améliore la qualité de vie chez les patients souffrant de fibrillation auriculaire, et réduit, de plus leur fréquence cardiaque et leur pression artérielle souligne cette étude, Ses conclusions, présentées dans l'European Journal of Cardiovascular Nursing, font en effet valoir, après un programme de 12 semaines seulement, une m...

Brexit: MHRA Grilling Gives A Regulator's View Of The Stakes

UK medicines agency chief notes his agency's key role in initiatives such as PRIME and the value of a regulatory network across the EU.

An overview of pharmacy practice in developing countries

‘Pharmacy practice in developing countries’, edited by Ahmed Ibrahim Fathelrahman, Mohamed Izham Mohamed Ibrahim and Albert I Wertheimer.

Seafloor geodetic constraints on interplate coupling of the Nankai Trough megathrust zone

Interplate megathrust earthquakes have inflicted catastrophic damage on human society. Such an earthquake is predicted to occur in the near future along the Nankai Trough off southwestern Japan—an economically active and densely populated area in which megathrust earthquakes have already occurred. Megathrust earthquakes are the result of a plate-subduction mechanism and occur at slip-deficit reg...

STAR Institute for Sensory Processing Disorder Announces New Director

STAR Institute for Sensory Processing Disorder (SPD) has announced the selection of Dick Layton as its new director. Denver, CO (PRWEB) May 31, 2016 STAR Institute for Sensory Processing Disorder (SPD) has announced the selection of Dick Layton as its new director. STAR Institute is the newly merged organization of STAR Center and SPD Foundation. With Dick Layton in position the STAR Institute is...

ASCO 2016: Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery

A European phase III trial, one of the largest ever conducted in pancreatic cancer, showed that adding the oral drug capecitabine chemotherapy to gemcitabine prolongs survival without increased toxicity. Adjuvant gemcitabine chemotherapy is currently the...

Janssen’s Multiple Myeloma Combo Significantly Reduced Risk of Disease Progression in a Late-Stage Trial

CHICAGO and RARITAN, NJ, June 5, 2016 – Data from the Phase 3 MMY3004 (CASTOR) clinical trial show the immunotherapy daratumumab (DARZALEX®) in combination with a standard of care therapy, bortezomib (a proteasome inhibitor [PI]) and dexamethasone (a corticosteroid), demonstrated a 61 percent reduction in the risk of disease progression or death (progression-free survival, or …

Results from SCHOLAR-1 trial for DLBCL patients

Prof Gisselbrecht talks to ecancertv at EHA 2016 about the SCHOLAR-1 trial, identifying patient cohorts most likely to respond to aggressive diffuse large B-cell lymphoma (DLBCL). He describes patient selection from an initial pool of over 800 eligible...

BRIEF-Epirus Biopharmaceuticals enters term sheet with Zaklady Farmaceutyczne

* On June 13, 2016, entered into a binding term sheet with Zaklady Farmaceutyczne 'Polpharma' S.A.

INFECTIONS URINAIRES: Antibiotiques ou…cranberries? - American Journal of Clinical Nutrition

De nombreuses études ont porté sur les bénéfices des cranberries (ou canneberges) dans la prévention des infections des voies urinaires et plus largement dans la prévention des infections bactériennes, mais avec des conclusions contradictoires. La Cochrane Review avait mis fin au mythe, avec une méta-analyse concluant à l'absence&...

Napster founder funding CRISPR use in cancer research, wants to make science available to all

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. The first proposed test of CRISPR gene-editing technology in human beings is being funded by Internet billionaire Sean Parker, a 36-year-old whose net worth is estimated at $2.4 billion. Penn confirmed Parker’s charitable foundation would be funding the trial. […] The post Napster...

ACIP Nixes Nasal Spray Influenza Vaccine for Next Season

The CDC's ACIP has recommended that live attenuated influenza vaccine, the nasal spray influenza vaccine, should not be used because it was ineffective during the last three influenza seasons. Medscape Medical News

KBI Biopharma: How to stand out in the CMO space

KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challenges of staying competitive in the CMO sector.

World Biosimilar Congress Europe 2016

World Biosimilar Congress 14‒15 November 2016 Congress Center BaselBasel, Switzerland 

Hepatitis C: Let's Get 'Real'

Clinical trials have shown that current treatment approaches for hepatitis C are highly successful. Can this degree of success be attained in real-world populations? Medscape Gastroenterology

Brexit Timebomb: Expect Effects On Drug Regulation, IP, Research And Trade

The UK's decision to leave the EU will have a wide range of effects on the life sciences sector, from drug approvals and clinical research to data exclusivity, patents and trade.

Post-Brexit, will the European Medicines Agency be homeless?

Britain's vote to leave the European Union seems likely to cause major disruptions for the drug approval process.

VMS Rehab Systems, Inc. Eyes Anomaly in Stock Price

OTTAWA, Ontario, June 27, 2016 /PRNewswire/ -- VMS Rehab Systems, Inc. ( reported today that the Company's Board will take whatever measures required to build a strong and stable market for trading in the Company's stock which is currently listed on the OTC Markets-pink current trading platform. Explains Michael S Wexler, Company Chairman and CEO, "We are seeing an...

Allergy Partners Releases Smartphone App for Patient Use

There is now a mobile app for patients, integrated within Allergy Partners’ Patient Portal and EMR, which provides customized, interactive coaching for the patient’s specific condition and helps track medications, allergy injections, triggers, and symptoms. Asheville, North Carolina (PRWEB) June 28, 2016 There is now a mobile app for patients, integrated within Allergy Partners’ Patient Por...

Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China

Pfizer’s state-of-the-art facility will foster the continued development of the biotechnology industry in China, further supporting National healthcare reforms Hangzhou, China, June 28, 2016 – Pfizer Inc. today announced that it will invest approximately USD$350 million in the development of a state-of-the-art Global Biotechnology Center at a ground-breaking ceremony in the Hangzho...

Advinus Ex-CEO's Bitter-Sweet Journey And Lessons Learnt

Life appears to have come full circle for Advinus Therapeutics' co-founder and former CEO and managing director, Dr Rashmi Barbhaiya...      Related StoriesStockwatch: Damage Not ControlledINTERVIEW: Roche's Dan Chen Talks Immuno-Oncology CombinationsStockwatch: A Week Of Dashed Expectations 


It's good to share. Even better when it's in the interest of the health and wellbeing of the nation as well as the ongoing professional development of NHS staff. KnowledgeShare, a web application created by Brighton and Sussex University Hospitals NHS Trust and built by software developers Maldaba Ltd, is achieving just that and word is spreading fast! Currently available to around 1...

uBiome Completely Re-Imagines Microbiome Experimentation with New Launch

uBiome, the leading microbial genomics company, has launched the uBiome Explorer, a user website that includes scores based on characteristics of the microbiome (such as diversity or probiotic bacteria) and recommendations for food and wellness experiments that citizen scientists can perform. San Francisco, CA (PRWEB) June 29, 2016 Microbial genomics leader uBiome has released the uBiome Explorer...

PRC Clinical Strengthens CRO Expertise In Regenerative Medicine

PRC Clinical, a Silicon Valley based Clinical Contract Research Organization (CRO) Has Been Selected To Conduct A Parkinson’s Disease Gene Therapy Study. San Bruno, CA (PRWEB) June 30, 2016 PRC Clinical, a Silicon Valley based Clinical Contract Research Organization (CRO) specializing in Clinical Trial Management and Clinical Trial Services, is expanding its gene therapy and Parkinson’s disea...

Shire Announces Top-Line Results for Phase 2 Trial of SHP607 in Extremely Premature Infants

LEXINGTON, Massachusetts, June 30, 2016 /PRNewswire/ -- Top-line SHP607 study results in extremely premature infants showed no impact on primary endpoint of reducing the severity of Retinopathy of Prematurity  Top-line analysis of secondary endpoints showed clinically relevant effects on severe complications related to lung and brain damage   These data support fu...

BRIEF-Nanjing Xinjiekou Dept Store plans to buy stakes in Cordlife Group

June 30 (Reuters) - Nanjing Xinjiekou Department Store Co Ltd

?Maleness? Gene Found in Malaria Mosquito

Researchers have identified the male-determining gene in the malaria mosquito, whose expression in females is lethal.

Quick Search